Form 4: USANA Health Sciences Director Timothy Wood Reports Stock Transactions
SEC Form 4
Director Timothy Wood reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On May 2, 2025, Timothy Wood, a director of USANA Health Sciences Inc., had restricted stock units vest, resulting in the acquisition of 674 shares of common stock.
- Simultaneously, 169 shares were disposed of to cover tax obligations at a price of $29.44 per share.
- Following these transactions, Wood directly owns 7,442 shares of USANA common stock.
Sentiment
Score: 5
Explanation: This Form 4 filing is a routine disclosure of insider transactions related to stock vesting and tax obligations, and does not inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be an indicator of management's confidence in the company's prospects.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in financial analysis.
- Comparing the volume and frequency of insider transactions at USANA to those of its competitors (e.g., Herbalife, Nu Skin) can provide insights into relative management sentiment and potential future performance.
- However, it's important to note that insider transactions can be driven by a variety of factors, including personal financial planning, and may not always be indicative of the company's prospects.
Stakeholder Impact
- The transactions have a minimal impact on shareholders, as they represent a small percentage of the total outstanding shares.
- Employees who hold restricted stock units are directly affected by the vesting schedule.
Key Dates
| Date | Description |
|---|---|
| 08/02/2024 | 25% of Restricted Stock Units vest |
| 11/02/2024 | 25% of Restricted Stock Units vest |
| 02/02/2025 | 25% of Restricted Stock Units vest |
| 05/02/2025 | 25% of Restricted Stock Units vest, acquisition of 674 shares, disposition of 169 shares for tax obligations |
| 05/06/2025 | Date of Form 4 filing |
Keywords
USANA Health Sciences, Director, Stock Transaction, Form 4, Beneficial Ownership, Restricted Stock Units, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.